Omeros Corporation
OMER
$3.53
Share price
-3.02%
Change (1 day)
-29.40%
Change (1 year)
Categories
Omeros Corporation (OMER) - P/B ratio
P/B ratio as of May 2024 : -15.1
According to Omeros Corporation's latest financial reports the company has a price-to-book ratio of -15.1.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Omeros Corporation - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -14.7 | -990.51% |
| 2022-12-31 | 1.65 | -90.23% |
| 2021-12-31 | 16.9 | -332.12% |
| 2020-12-31 | -7.30 | 4.15% |
| 2019-12-31 | -7.00 | 28.5% |
| 2018-12-31 | -5.45 | -98.36% |
| 2017-12-31 | -331 | 2815.49% |
| 2016-12-31 | -11.4 | -50.16% |
| 2015-12-31 | -22.8 | 14.85% |
| 2014-12-31 | -19.9 | 6.52% |
| 2013-12-31 | -18.6 | -9.41% |
| 2012-12-31 | -20.6 | 29.42% |
| 2011-12-31 | -15.9 | -280.2% |
| 2010-12-31 | 8.82 | 154.79% |
| 2009-12-31 | 3.46 | |
| 2008-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.11 | -133.81% | 🇺🇸 USA |
 Pfizer PFE | 1.76 | -111.65% | 🇺🇸 USA |
 Genetic Technologies GENE | 3.28 | -121.67% | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | 4.80 | -131.73% | 🇺🇸 USA |